Hikma Pharmaceuticals (LON:HIK) Sets New 52-Week Low – What’s Next?

Shares of Hikma Pharmaceuticals PLC (LON:HIK) reached a new 52-week low on Thursday . The stock traded as low as GBX 4.32 ($0.05) and last traded at GBX 2,134 ($26.27), with a volume of 784546 shares traded. The stock had previously closed at GBX 2,130 ($26.22).

Hikma Pharmaceuticals Stock Performance

The stock has a market cap of £4.74 billion, a price-to-earnings ratio of 3,289.23, a P/E/G ratio of 2.38 and a beta of 0.41. The company has a current ratio of 1.66, a quick ratio of 1.27 and a debt-to-equity ratio of 55.48. The firm has a fifty day simple moving average of GBX 1,959.25 and a 200-day simple moving average of GBX 1,932.89.

About Hikma Pharmaceuticals

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.